Bari, Italy – October 2024: The First International Congress of the Italian and International Academy of Hemodynamic Phlebology (AIIFEm) recently concluded in Bari, Italy, marking a significant milestone in the field of venous surgery and hemodynamic phlebology. This groundbreaking event gathered top experts and researchers from across the globe to discuss the latest advancements and future directions of the CHIVA method, a surgical technique for treating varicose veins.
The two-day conference, chaired by the esteemed Dr. Antonio Di Gioia, featured a robust scientific program designed to explore the origins, current state, and future of the CHIVA method. The congress commenced with a series of keynote presentations that traced the development of CHIVA, highlighting its global impact and the integration of cutting-edge technologies like Artificial General Intelligence (AGI) in CHIVA centers.
Key Highlights:
- Historical and Global Perspectives: Presentations by leading experts, including Claude Franceschi and Jordi Juan Samsó, provided an in-depth look at the evolution of CHIVA over the past 36 years, with a focus on its global expansion from Europe to China.
- Innovative Applications: The application of AGI in the management of varicose veins was a notable topic, with Q. Smile Zhang discussing the transformative potential of this technology in improving patient outcomes.
- Critical Discussions: A significant portion of the meeting was dedicated to critical topics in CHIVA strategy, such as the treatment of type 3 shunt and the preservation of the great saphenous vein (GSV) in vascular surgery. These discussions were led by internationally renowned chairs and discussants, fostering a rich exchange of knowledge and best practices.
- CHIVA Around the World: The global adoption of the CHIVA method was underscored through presentations that covered its implementation and success stories from various countries, including South Korea, Croatia, and Brazil.
- Research and Clinical Trials: The congress also served as a platform for presenting long-term research studies, including a 20-year follow-up of randomized controlled trials comparing the CHIVA method to traditional varicose vein surgery.
Educational Impact:
The congress was not only a scientific gathering but also an educational forum. A special session on the pathophysiology of chronic venous insufficiency provided participants with a comprehensive understanding of the hemodynamic principles that underpin the CHIVA method. This was complemented by live echo duplex evaluations, offering hands-on experience in advanced diagnostic techniques.
Looking Ahead:
The success of this inaugural congress sets the stage for future collaborations and innovations in the field of hemodynamic phlebology. The AIIFEm and its international partners are committed to advancing the CHIVA method and enhancing its global reach through ongoing research, education, and clinical practice improvements.
About AIIFEm:
The Italian and International Academy of Hemodynamic Phlebology (AIIFEm) is dedicated to the study and advancement of hemodynamic methods for the treatment of venous diseases. Through its congresses, educational programs, and research initiatives, AIIFEm aims to promote excellence in vascular surgery and patient care worldwide.
For more information about the congress or to register for future events, please visit the AIIFEm Link.